<DOC>
	<DOCNO>NCT01572064</DOCNO>
	<brief_summary>The main purpose pilot study evaluate non-invasive magnetic resonance imaging ( MRI ) techniques detection grade liver fibrosis , investigator reduce need invasive technique liver biopsy transjugular hepatic venous portal pressure gradient ( HVPG ) measurement assess degree liver scar portal hypertension .</brief_summary>
	<brief_title>Magnetic Resonance Imaging Evaluation Liver Fibrosis</brief_title>
	<detailed_description>In chronic liver diseases aetiology , persistent hepatocyte injury lead progressive fibrosis cirrhosis . In UK , 76 adult per 100,000 population cirrhosis incidence increase ( Fleming et al. , J Hepatol 2008,49 , p732-738 ) . Currently , liver biopsy method assess degree fibrosis . However , liver biopsy associate limitation sample error , intra- inter-observer variation interpretation adverse event ( Morbidity 1-5 % mortality 1 1,000 1 10,000 ) , hence consider 'Silver ( rather Gold ) standard ' . Assessment degree fibrosis necessary stage disease process , determine time intervention prognosis . Development portal hypertension result progressive fibrosis landmark natural history chronic liver diseases account majority complication clinical outcome . The degree fibrosis presence portal hypertension determine whether patient include surveillance programme early detection varix hepatocellular carcinoma . As assessment degree fibrosis , presence degree portal hypertension determine transjugular hepatic venous portal pressure gradient ( HVPG ) measurement , another investigation also hamper access , cost , risk difficulty serial measurement . A variety evolve technique use magnetic resonance imaging ( MRI ) ( Talwalkar et al. , Hepatology 2008 ; 47:332-42 ) validate establish , potential replace liver biopsy HVPG measurement . The non-invasive nature MRI , ability estimate amount accumulate fat ( 1H MR spectroscopy ) , cell membrane turnover ( 31P-MRS ) , iron ( relaxometry ) , fibrosis ( MR elastography ) well ability assess portal blood flow hepatic perfusion ( Arterial Spin Labelling ( ASL ) ) make ideal tool evaluate liver structure function stage liver disease . Most recently , MRI see unprecedented development term accuracy quantitation speed assessment , realise due data-sharing ultra-fast MRI sequence , multispectral analysis , refinement elastography method . Validation evolve MRI technique liver biopsy , HVPG metabolomics critical step prior translation clinical application creation MRI biomarkers .</detailed_description>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<criteria>Liver biopsy within last 3 month Underlying chronic liver disease hepatitis C , alcoholic liver disease , nonalcoholic fatty liver disease , hepatitis B , haemochromatosis biopsy consider normal . Ability consent participate study Inadequate biopsy length histology Absolute contraindication MRI Abdominal/waist circumference great 112 cm ( 44 inch ) , due scanner bore constraint Pregnant woman</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>MRI</keyword>
	<keyword>liver biopsy</keyword>
	<keyword>serological marker</keyword>
</DOC>